These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8083146)
1. Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children. Rapport MD; Denney C; DuPaul GJ; Gardner MJ J Am Acad Child Adolesc Psychiatry; 1994; 33(6):882-93. PubMed ID: 8083146 [TBL] [Abstract][Full Text] [Related]
2. Does methylphenidate normalize the classroom performance of children with attention deficit disorder? DuPaul GJ; Rapport MD J Am Acad Child Adolesc Psychiatry; 1993 Jan; 32(1):190-8. PubMed ID: 8428871 [TBL] [Abstract][Full Text] [Related]
3. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Research Units on Pediatric Psychopharmacology Autism Network Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814 [TBL] [Abstract][Full Text] [Related]
4. Response of children with ADHD to methylphenidate: interaction with internalizing symptoms. DuPaul GJ; Barkley RA; McMurray MB J Am Acad Child Adolesc Psychiatry; 1994; 33(6):894-903. PubMed ID: 8083147 [TBL] [Abstract][Full Text] [Related]
5. Titrating methylphenidate in children with attention-deficit/hyperactivity disorder: is body mass predictive of clinical response? Rapport MD; Denney C J Am Acad Child Adolesc Psychiatry; 1997 Apr; 36(4):523-30. PubMed ID: 9100427 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data. Sonuga-Barke EJ; Swanson JM; Coghill D; DeCory HH; Hatch SJ BMC Psychiatry; 2004 Sep; 4():28. PubMed ID: 15458569 [TBL] [Abstract][Full Text] [Related]
7. Dose-response effects of methylphenidate on academic performance and overt behavior in hyperactive children. Tannock R; Schachar RJ; Carr RP; Logan GD Pediatrics; 1989 Oct; 84(4):648-57. PubMed ID: 2780127 [TBL] [Abstract][Full Text] [Related]
8. Effects of late-afternoon methylphenidate administration on behavior and sleep in attention-deficit hyperactivity disorder. Kent JD; Blader JC; Koplewicz HS; Abikoff H; Foley CA Pediatrics; 1995 Aug; 96(2 Pt 1):320-5. PubMed ID: 7630692 [TBL] [Abstract][Full Text] [Related]
9. Executive impairment determines ADHD medication response: implications for academic achievement. Hale JB; Reddy LA; Semrud-Clikeman M; Hain LA; Whitaker J; Morley J; Lawrence K; Smith A; Jones N J Learn Disabil; 2011; 44(2):196-212. PubMed ID: 21383110 [TBL] [Abstract][Full Text] [Related]
10. Sustained attention, activation and MPH in ADHD: a research note. van der Meere J; Shalev R; Börger N; Gross-Tsur V J Child Psychol Psychiatry; 1995 May; 36(4):697-703. PubMed ID: 7650092 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD. Handen BL; Feldman HM; Lurier A; Murray PJ J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):805-12. PubMed ID: 10405497 [TBL] [Abstract][Full Text] [Related]
12. Predicting methylphenidate response in children with ADHD: theoretical, empirical, and conceptual models. Denney CB; Rapport MD J Am Acad Child Adolesc Psychiatry; 1999 Apr; 38(4):393-401. PubMed ID: 10199110 [TBL] [Abstract][Full Text] [Related]
13. Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. Mulhern RK; Khan RB; Kaplan S; Helton S; Christensen R; Bonner M; Brown R; Xiong X; Wu S; Gururangan S; Reddick WE J Clin Oncol; 2004 Dec; 22(23):4795-803. PubMed ID: 15570081 [TBL] [Abstract][Full Text] [Related]
14. The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder. Coghill DR; Rhodes SM; Matthews K Biol Psychiatry; 2007 Nov; 62(9):954-62. PubMed ID: 17543895 [TBL] [Abstract][Full Text] [Related]
15. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM; Earls MF Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972 [TBL] [Abstract][Full Text] [Related]
16. Effects of methylphenidate on attention and nonverbal learning in children with attention-deficit hyperactivity disorder. O'Toole K; Abramowitz A; Morris R; Dulcan M J Am Acad Child Adolesc Psychiatry; 1997 Apr; 36(4):531-8. PubMed ID: 9100428 [TBL] [Abstract][Full Text] [Related]
17. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biederman J; Mick E; Surman C; Doyle R; Hammerness P; Harpold T; Dunkel S; Dougherty M; Aleardi M; Spencer T Biol Psychiatry; 2006 May; 59(9):829-35. PubMed ID: 16373066 [TBL] [Abstract][Full Text] [Related]
18. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes. Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386 [TBL] [Abstract][Full Text] [Related]
19. School observations of children with attention-deficit hyperactivity disorder and comorbid tic disorder: effects of methylphenidate treatment. Gadow KD; Nolan E; Sprafkin J; Sverd J J Dev Behav Pediatr; 1995 Jun; 16(3):167-76. PubMed ID: 7560119 [TBL] [Abstract][Full Text] [Related]
20. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD. Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]